What Fueled The Previous Growth In The Bioprocessing Technology Market?
The bioprocessing technology market has seen considerable growth due to a variety of factors.
• In recent times, the bioprocessing technology market size has seen significant growth. The market is projected to expand from $25.1 billion in 2024 to $29.06 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.8%.
The historical period witnessed this growth due to factors such as a surge in demand for biopharmaceuticals, growth and expansion within the biotechnology and life science sectors, increased investments in research and development, the globalization of the biopharmaceutical market, and an emphasis on improving cost-efficiency and optimizing processes.
What Can Be Expected from the Bioprocessing Technology Market?
The bioprocessing technology market is expected to maintain its strong growth trajectory in upcoming years.
• A significant surge is anticipated in the bioprocessing technology market in the coming years, with its value estimated to rise to $49.92 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 14.5%.
This impending growth during the forecast period can be credited to factors like the expansion of biomanufacturing capacities, the advent of innovative therapies, the rising significance of single-use bioprocessing systems, escalated deployment of continuous bioprocessing, and strategic relationships and partnerships. Key trends during the forecast period will feature personalized and precision bioprocessing, regulatory compliance and quality assurance, global spread of biopharmaceutical processing, environmental sustainability, along with collaborations and partnerships.
What Are The Core Factors Supporting Growth In The Bioprocessing Technology Market?
The escalating prevalence of chronic illnesses is predicted to boost the advancement of the bioprocessing technology market. Chronic illnesses are persistent health issues lasting at least a year, disrupting daily routines, necessitating continuous medical supervision, or both. Bioprocessing technology incorporates the creation of therapeutic proteins, polysaccharides, vaccines, and diagnostic essentials for managing these illnesses. Consequently, the rising prevalence of chronic diseases will underpin the growth of the bioprocessing technology market. For example, the World Health Organization, based in Switzerland and a branch of the United Nations, estimated in February 2024 that over 35 million fresh cancer diagnoses would be registered by 2050. This represents a 77% surge in comparison to the projected 20 million cases witnessed in 2022. Thus, the mounting occurrences of chronic diseases will propel the growth of the bioprocessing technology market.
How Is The Bioprocessing Technology Market segmented?
The bioprocessing technology market covered in this report is segmented –
1) By Product: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration
2) By Application: Antibiotics, Biosimilars, Recombinant Proteins, Other Applications
3) By End Use: Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed Industry, Contract Research Organization
Subsegments:
1) By Biologics Safety Testing: Endotoxin Testing, Sterility Testing, Viral Safety Testing
2) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
3) By Cell Expansion: Manual Cell Expansion, Automated Cell Expansion
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Flow Cytometry: Cell Sorting, Cell Analysis
6) By Tangential Flow Filtration: Microfiltration, Ultrafiltration
Pre-Book The Bioprocessing Technology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Bioprocessing Technology Market?
The emergence of innovative bioprocessing technology is a notable trend making waves in the bioprocessing technology market. To maintain their market stance, leading firms in the bioprocess technology sector are focusing on technological advancements. For instance, Univercells Technologies Inc., a biotech firm based in Belgium, introduced its new scale-x technology, the scale-X cell collect module, in October 2022. This ground-breaking solution aims to streamline the inoculation stage for large-scale bioreactors by employing the principles of automation and intensification. The scale-X is engineered to decrease aseptic risks and deliver high repeatability, whilst diminishing costs, operation time, and space requirements.
Who Are the Key Players In The Bioprocessing Technology Market?
Major companies operating in the bioprocessing technology market report are:
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Merck KGaA
• Danaher Corporation
• Lonza Group AG
• GE Healthcare
• Waters Corporation
• STADA Arzneimittel AG
• Bio-Rad Laboratories Inc.
• Applikon Biotechnology B.V.
• Agilent Technologies Inc.
• Solida Biotech GmbH
• Fujifilm Healthcare Corporation
• Catalent Inc.
• Asahi Kasei Medical Inc.
• Amgen Inc.
• Eppendorf AG
• Repligen Corporation
• Becton Dickinson and Company
• MilliporeSigma
• Novasep
• Boehringer Ingelheim GmbH
• Cytiva AB
• Wuxi Biologics
• AGC Biologics
• Samsung Biologics
• AbbVie Inc.
• Bristol Myers Squibb Company
• Pfizer Inc.
• Roche Holding AG
What Is The Most Dominant Region In The Bioprocessing Technology Market?
North America was the largest region in the bioprocessing technology market in 2023. The regions covered in the bioprocessing technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
